Pfizer has launched its mobile app and website, ATLAS, this week in an effort to help insurers, physicians, and everyday consumers track resistance rates and drug trends. The app allows users to see global resistance rates as well as pinpointed areas around the world. The app will be updated every six months with correct data and already includes all 13 years of Pfizer-specific data. Read the full release here.